409 related articles for article (PubMed ID: 22078026)
1. The microenvironment in breast cancer progression: biology and implications for treatment.
Place AE; Jin Huh S; Polyak K
Breast Cancer Res; 2011; 13(6):227. PubMed ID: 22078026
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.
Domínguez-Cejudo MA; Gil-Torralvo A; Cejuela M; Molina-Pinelo S; Salvador Bofill J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069096
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
5. Role of the Tumor Microenvironment in Breast Cancer.
Soysal SD; Tzankov A; Muenst SE
Pathobiology; 2015 Sep; 82(3-4):142-52. PubMed ID: 26330355
[TBL] [Abstract][Full Text] [Related]
6. Stromal cells in tumor microenvironment and breast cancer.
Mao Y; Keller ET; Garfield DH; Shen K; Wang J
Cancer Metastasis Rev; 2013 Jun; 32(1-2):303-15. PubMed ID: 23114846
[TBL] [Abstract][Full Text] [Related]
7. The biological and clinical significance of stromal-epithelial interactions in breast cancer.
McCuaig R; Wu F; Dunn J; Rao S; Dahlstrom JE
Pathology; 2017 Feb; 49(2):133-140. PubMed ID: 28040198
[TBL] [Abstract][Full Text] [Related]
8. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of microinvasive breast cancer microenvironment progression.
Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
12. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression.
Holliday DL; Brouilette KT; Markert A; Gordon LA; Jones JL
Breast Cancer Res; 2009; 11(1):R3. PubMed ID: 19152687
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
[TBL] [Abstract][Full Text] [Related]
15. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
17. The role of cancer-associated fibroblasts in breast cancer pathobiology.
Jung YY; Kim HM; Koo JS
Histol Histopathol; 2016 Apr; 31(4):371-8. PubMed ID: 26627101
[TBL] [Abstract][Full Text] [Related]
18. Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis.
Smith L; Baxter EW; Chambers PA; Green CA; Hanby AM; Hughes TA; Nash CE; Millican-Slater RA; Stead LF; Verghese ET; Speirs V
PLoS One; 2015; 10(10):e0139698. PubMed ID: 26437339
[TBL] [Abstract][Full Text] [Related]
19. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
20. miRNAs: Critical mediators of breast cancer metastatic programming.
Nair MG; Somashekaraiah VM; Ramamurthy V; Prabhu JS; Sridhar TS
Exp Cell Res; 2021 Apr; 401(1):112518. PubMed ID: 33607102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
